Ro67-4853
Ro67-4853
Ro67-4853 (/roʊˈsɪkstiːˈfɔːrˈfaɪvˈθriː/) is a pharmacological compound of interest in the field of neuroscience.
Etymology
The name "Ro67-4853" is derived from the naming convention used by the pharmaceutical company Roche, which discovered the compound. The "Ro" stands for Roche, while the numbers "67-4853" are a unique identifier for the compound.
Description
Ro67-4853 is a potent and selective antagonist of the NMDA receptor, specifically targeting the NR2B subunit. The NMDA receptor is a type of ionotropic glutamate receptor that is important for controlling synaptic plasticity and memory function. By blocking this receptor, Ro67-4853 can modulate these processes.
Related Terms
- NMDA receptor antagonist: A type of drug that reduces the activity of the NMDA receptors in the brain. Ro67-4853 is a specific type of NMDA receptor antagonist.
- Neuropharmacology: The study of how drugs affect cellular function in the nervous system. Ro67-4853 is a compound of interest in this field.
- Synaptic plasticity: The ability of synapses to strengthen or weaken over time, in response to increases or decreases in their activity. Ro67-4853 can modulate this process by blocking NMDA receptors.
- Memory function: The cognitive process that allows information to be encoded, stored, and retrieved. Ro67-4853 can affect this process by modulating the activity of NMDA receptors.
External links
- Medical encyclopedia article on Ro67-4853
- Wikipedia's article - Ro67-4853
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski